Han YH, Kim SZ, Kim SH, Park WH

Avoid this treatment if: You have been diagnosed with type 1 diabetes You are pregnant, trying to become pregnant, or breastfeeding You have severe digestive conditions, including gastroparesis (delayed stomach emptying) You have an allergy to tirzepatide or any ingredient listed in the medication You are under 18 You should also speak to a healthcare professional before starting Mounjaro if you have any of the following, as extra caution or monitoring may be needed: A history of pancreatitis Gallbladder problems, including gallstones Significant kidney disease or dehydration risk (especially if you are prone to vomiting) Liver problems Diabetic eye disease (diabetic retinopathy), particularly if your blood sugars may change quickly A history of severe allergic reactions to injectable medicines You take other diabetes medications, especially insulin or sulfonylureas, as your risk of low blood sugar may be higher As with any prescription weight loss treatment, ongoing monitoring is important

Does a GLP-1 Quiet the Wine Itself Here is where it gets interesting
Long-term success comes from steady habits, good medical guidance and realistic expectations
Oh my God, thats so crazy
In the past ten years, a series of Phase III trials showed that the synthetic GLP-1/GIP agonists are effective in lowering blood sugar in type 2 diabetic subjects who were both treatment-nave or on typical first-line therapies such as metformin and insulin